1
|
Karmali D, Sowho M, Bose S, Pearce J, Tejwani V, Diamant Z, Yarlagadda K, Ponce E, Eikelis N, Otvos T, Khan A, Lester M, Fouras A, Kirkness J, Siddharthan T. Functional imaging for assessing regional lung ventilation in preclinical and clinical research. Front Med (Lausanne) 2023; 10:1160292. [PMID: 37261124 PMCID: PMC10228734 DOI: 10.3389/fmed.2023.1160292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Accepted: 04/17/2023] [Indexed: 06/02/2023] Open
Abstract
Dynamic heterogeneity in lung ventilation is an important measure of pulmonary function and may be characteristic of early pulmonary disease. While standard indices like spirometry, body plethysmography, and blood gases have been utilized to assess lung function, they do not provide adequate information on regional ventilatory distribution nor function assessments of ventilation during the respiratory cycle. Emerging technologies such as xenon CT, volumetric CT, functional MRI and X-ray velocimetry can assess regional ventilation using non-invasive radiographic methods that may complement current methods of assessing lung function. As a supplement to current modalities of pulmonary function assessment, functional lung imaging has the potential to identify respiratory disease phenotypes with distinct natural histories. Moreover, these novel technologies may offer an optimal strategy to evaluate the effectiveness of novel therapies and therapies targeting localized small airways disease in preclinical and clinical research. In this review, we aim to discuss the features of functional lung imaging, as well as its potential application and limitations to adoption in research.
Collapse
Affiliation(s)
- Dipan Karmali
- Division of Pulmonary and Critical Care, Leonard M. Miller School of Medicine, University of Miami, Coral Gables, FL, United States
| | - Mudiaga Sowho
- Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD, United States
| | - Sonali Bose
- Division of Pulmonary and Critical Care, Icahn School of Medicine, Mount Sinai, NY, United States
| | - Jackson Pearce
- School of Medicine, Medical University of South Carolina, Charleston, SC, United States
| | - Vickram Tejwani
- Respiratory Institute, Cleveland Clinic, Cleveland, OH, United States
| | - Zuzana Diamant
- Department of Microbiology Immunology and Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium
- Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden
- Department Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
| | - Keerthi Yarlagadda
- Division of Pulmonary and Critical Care, Leonard M. Miller School of Medicine, University of Miami, Coral Gables, FL, United States
| | - Erick Ponce
- Division of Pulmonary and Critical Care, Leonard M. Miller School of Medicine, University of Miami, Coral Gables, FL, United States
| | | | | | - Akram Khan
- Division of Pulmonary and Critical Care, Oregon Health and Science University, Portland, OR, United States
| | - Michael Lester
- Department of Pulmonary and Critical Care Medicine, Vanderbilt Medical Center, Nashville, CA, United States
| | | | | | - Trishul Siddharthan
- Division of Pulmonary and Critical Care, Leonard M. Miller School of Medicine, University of Miami, Coral Gables, FL, United States
| |
Collapse
|
2
|
Do TD, Skornitzke S, Merle U, Kittel M, Hofbaur S, Melzig C, Kauczor HU, Wielpütz MO, Weinheimer O. COVID-19 pneumonia: Prediction of patient outcome by CT-based quantitative lung parenchyma analysis combined with laboratory parameters. PLoS One 2022; 17:e0271787. [PMID: 35905122 PMCID: PMC9337660 DOI: 10.1371/journal.pone.0271787] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Accepted: 07/07/2022] [Indexed: 12/23/2022] Open
Abstract
Objectives To evaluate the prognostic value of fully automatic lung quantification based on spectral computed tomography (CT) and laboratory parameters for combined outcome prediction in COVID-19 pneumonia. Methods CT images of 53 hospitalized COVID-19 patients including virtual monochromatic reconstructions at 40-140keV were analyzed using a fully automated software system. Quantitative CT (QCT) parameters including mean and percentiles of lung density, fibrosis index (FIBI-700, defined as the percentage of segmented lung voxels ≥-700 HU), quantification of ground-glass opacities and well-aerated lung areas were analyzed. QCT parameters were correlated to laboratory and patient outcome parameters (hospitalization, days on intensive care unit, invasive and non-invasive ventilation). Results Best correlations were found for laboratory parameters LDH (r = 0.54), CRP (r = 0.49), Procalcitonin (r = 0.37) and partial pressure of oxygen (r = 0.35) with the QCT parameter 75th percentile of lung density. LDH, Procalcitonin, 75th percentile of lung density and FIBI-700 were the strongest independent predictors of patients’ outcome in terms of days of invasive ventilation. The combination of LDH and Procalcitonin with either 75th percentile of lung density or FIBI-700 achieved a r2 of 0.84 and 1.0 as well as an area under the receiver operating characteristic curve (AUC) of 0.99 and 1.0 for the prediction of the need of invasive ventilation. Conclusions QCT parameters in combination with laboratory parameters could deliver a feasible prognostic tool for the prediction of invasive ventilation in patients with COVID-19 pneumonia.
Collapse
Affiliation(s)
- Thuy D. Do
- Clinic for Diagnostic and Interventional Radiology (DIR), University Hospital Heidelberg, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany
| | - Stephan Skornitzke
- Clinic for Diagnostic and Interventional Radiology (DIR), University Hospital Heidelberg, Heidelberg, Germany
| | - Uta Merle
- Department of Internal Medicine IV (Gastroenterology and Infectious Disease), University Hospital Heidelberg, Heidelberg, Germany
| | - Maximilian Kittel
- Institute for Clinical Chemistry, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany
| | - Stefan Hofbaur
- Clinic for Gastroenterology and Nephrology, Landshut Hospital, Landshut, Germany
| | - Claudius Melzig
- Clinic for Diagnostic and Interventional Radiology (DIR), University Hospital Heidelberg, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany
| | - Hans-Ulrich Kauczor
- Clinic for Diagnostic and Interventional Radiology (DIR), University Hospital Heidelberg, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany
- Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany
| | - Mark O. Wielpütz
- Clinic for Diagnostic and Interventional Radiology (DIR), University Hospital Heidelberg, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany
- Department of Diagnostic and Interventional Radiology with Nuclear Medicine, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany
| | - Oliver Weinheimer
- Clinic for Diagnostic and Interventional Radiology (DIR), University Hospital Heidelberg, Heidelberg, Germany
- Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany
- * E-mail:
| |
Collapse
|